Pharvaris N.v. sell PlusUltra
Start price
09.01.22
/
0%
€16.10
Target price
09.01.23
-
Performance (%)
-43.17%
End price
15.09.22
€9.15
Summary
This prediction ended on 15.09.22 with a price of €9.15. PlusUltra correctly predicted massive losses of -43.17% for Pharvaris N.v.. This prediction was marked as speculative and is excluded from PlusUltra's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Pharvaris N.v. | - | - | - |
iShares Core DAX® | 1.051% | -1.833% | 12.822% |
iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
iShares S&P 500 | 0.002% | -2.226% | 28.387% |
According to PlusUltra what are the pros and cons of Pharvaris N.v. for the foreseeable future?
Pros
Capable Management
Cons
Probably not worthwhile Investment
High valuation
Below average Marketposition
Comments by PlusUltra for this prediction
In the thread Discuss Pharvaris N.v.
Sell Pharvaris N.v.